NASDAQ:ALIM

Alimera Sciences - ALIM News Today

$1.95

+0.10 (+5.41%)

(As of 03/28/2023 12:00 AM ET)

Add

Compare

Today's Range: $1.80
▼
$2.00
50-Day Range: $1.35
▼
$2.94
52-Week Range: $1.30
▼
$7.92

Volume: 44,472 shs
Average Volume: 21,254 shs
Market Capitalization: $13.65 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $6.75

Institutional Ownership

Get Alimera Sciences News Delivered to You Automatically

ALIM Media Mentions By Week

ALIM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALIM
News Sentiment
▼
0.67

0.61
▲
Average
Medical
News Sentiment

ALIM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALIM Articles
This Week
▼
13

1
▲
ALIM Articles
Average Week

Source

Source	Headline
	Global Non-Infectious Macular Edema Treatment Market to Reach $22.4 Billion by 2030 finance.yahoo.com - March 28 at 1:09 PM
	8-K: ALIMERA SCIENCES INC marketwatch.com - March 28 at 1:09 PM
	Alimera Sciences Shares Rise 18% After Capital Restructuring marketwatch.com - March 27 at 1:45 PM
	Alimera Improves Capital Structure, Strengthens Balance Sheet and Extends Term Loan Facility finance.yahoo.com - March 27 at 1:45 PM
	Proliferative Diabetic Retinopathy Market Share by 2031 marketwatch.com - March 26 at 12:37 PM
	Alimera Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 31, 2023, and Provide Corporate Update finance.yahoo.com - March 24 at 7:08 PM
	Macular Degeneration Treatment Global Market Report 2023 finance.yahoo.com - March 24 at 2:07 PM
	Diabetic Retinopathy Market Outlook to 2028 marketwatch.com - March 23 at 8:45 PM
	StockNews.com Initiates Coverage on Alimera Sciences (NASDAQ:ALIM) americanbankingnews.com - March 23 at 2:58 AM
	Uveitis Treatment Market Size and Updated Report, Estimates & Forecast, By Application, segments 2023-2031 marketwatch.com - March 22 at 11:07 PM
	Ophthalmology Biologics Market Share and Forecast till 2031 marketwatch.com - March 22 at 1:18 AM
	Ocular Inflammation Treatment Market Growth and Forecast till 2028 marketwatch.com - March 17 at 8:29 AM
	Ocular Inflammation Treatment Market To Observer Consistent Development All through Forecast Period 2023-2030 marketwatch.com - March 8 at 7:40 AM
	2023-2029 Retinal Vein Occlusion Market Size and Risks Factors Analysis \| Survey Report by Absolute Reports marketwatch.com - March 2 at 7:38 AM
	Alimera Appoints Roger Sawhney, M.D. to Its Board of Directors finance.yahoo.com - February 27 at 10:42 AM
	Age-related Macular Degeneration Market Size 2023 with Pre COVID-19 and Post COVID-19 Market Scenario and Forecast till 2025 marketwatch.com - February 23 at 5:03 PM
	H.C. Wainwright Reaffirms Their Buy Rating on Alimera (ALIM) markets.businessinsider.com - February 23 at 9:11 AM
	Alimera Announces Submission of Marketing Authorization Application in Switzerland for ILUVIEN® finance.yahoo.com - February 22 at 12:32 PM
	Diabetic Retinopathy Market Size Global Research Report, 2023 - 2028 marketwatch.com - February 21 at 4:15 AM
	Global Ocular Inflammation Treatment Market Technology advancement and Latest Research Report 2023-2028 marketwatch.com - February 20 at 7:17 AM
	Intravitreal (IVT) Injectables Market : Global Market Growth, New Trends, COVID-19 Impact and Forecast 2023 To 2028 marketwatch.com - January 31 at 10:19 AM
	Diabetic Retinopathy Market International Business Analysis, Development Outlook and Regional Strategies 2028 marketwatch.com - January 30 at 8:41 AM
	Wet Age Related Macular Degeneration (AMD) Market Detailed Analysis of Current Industry Figures with Forecasts Regional Outlook 2028 marketwatch.com - January 13 at 6:09 PM
	Alimera Sciences Appoints Industry Veteran Russell L. Skibsted as Chief Financial Officer finance.yahoo.com - January 9 at 1:05 PM
	Diabetic Retinopathy Market 2023 : Recent Developments, Industry Trends and Investigation Growth Rate, and Forecast to 2028 marketwatch.com - January 5 at 6:23 AM
	Alimera Sciences, Inc. (NASDAQ:ALIM) Q3 2022 Earnings Call Transcript finance.yahoo.com - December 29 at 7:38 AM
	Looking Into Alimera Sciences's Return On Capital Employed msn.com - December 23 at 12:38 PM
	Wet Age Related Macular Degeneration (AMD) Market Provides an In-Depth Insight of Trends and Landscape Outlook 2022-2028 marketwatch.com - December 12 at 7:12 AM
	Alimera Sciences Announces Agreement to Extend Amortization Date and Interest-Only Period on Loan Agreement finance.yahoo.com - December 8 at 9:52 AM
	Alimera Highlights Abstracts Regarding Consensus Among US Retina Specialists and Reduced Retinal Thickness Variability Leading to Improved Visual Outcomes Following ILUVIEN® Administration finance.yahoo.com - November 29 at 9:36 AM
	7 Stocks That Could Implode at Any Moment finance.yahoo.com - November 25 at 1:59 AM
	Global Diabetic Retinopathy Market Report to 2027 - Featuring Bayer, Alimera Sciences, Novartis and Pfizer Among Others - ResearchAndMarkets.com businesswire.com - November 23 at 12:37 PM
	Alimera Sciences Third Quarter 2022 Earnings: Misses Expectations finance.yahoo.com - November 16 at 6:49 AM
	Alimera Sciences, Inc. (ALIM) Q3 2022 Earnings Call Transcript seekingalpha.com - November 15 at 2:45 AM
	Alimera Sciences, Inc.: Alimera Sciences Announces Third Quarter 2022 Financial Results finanznachrichten.de - November 14 at 11:35 AM
	Alimera Sciences Announces Third Quarter 2022 Financial Results finance.yahoo.com - November 14 at 11:35 AM
	Alimera Sciences (ALIM) Reports Q3 Loss, Lags Revenue Estimates finance.yahoo.com - November 14 at 11:35 AM
	Alimera Sciences Q3 2022 Earnings Preview seekingalpha.com - November 13 at 8:33 PM
	Global Diabetic Retinopathy Market Status and Trend 2022 Report by Competitive Landscape, Key Company Profiles, Types, Size and Forecast to 2028 marketwatch.com - November 7 at 10:32 AM
	Ocular Drug Delivery Technology Market Size, Sales, CAGR And Competition Data from 2022 To 2028 marketwatch.com - November 5 at 4:56 AM
	Alimera Sciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022, and Provide Corporate Update finance.yahoo.com - November 2 at 9:23 AM
	Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in the Czech Republic finance.yahoo.com - November 1 at 8:20 AM
	Is Alimera Sciences (ALIM) Stock Outpacing Its Medical Peers This Year? msn.com - October 20 at 11:47 AM
	10 Best Low Price Pharma Stocks To Buy Now finance.yahoo.com - October 18 at 9:20 AM
	Paladin Phase 4 Study Confirms ILUVIEN® Patients' Reduced Need for Multiple Treatments finance.yahoo.com - October 6 at 12:16 PM
	Alimera Announces Agreement with Jaeb Center for Health Research on Behalf of the DRCR Retina Network finance.yahoo.com - September 23 at 10:25 AM
	Alimera Sciences Inc ALIM Stock News morningstar.com - September 21 at 12:25 AM
	Alimera Announces Reimbursement of Uveitis Indication Granted for ILUVIEN® in Ireland finance.yahoo.com - September 20 at 7:25 PM
	Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year? finance.yahoo.com - September 19 at 1:09 PM
	Are Medical Stocks Lagging Alimera Sciences (ALIM) This Year? finance.yahoo.com - September 19 at 1:09 PM

Get Alimera Sciences News Delivered to You Automatically

This page (NASDAQ:ALIM) was last updated on 3/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alimera Sciences - ALIM News Today

ALIM Media Mentions By Week

ALIM Media Sentiment

ALIM News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info